<DOC>
	<DOCNO>NCT02449161</DOCNO>
	<brief_summary>Heavy menstrual bleeding common reason consultation gynecology define International Federation Gynecology Obstetrics perception menstrual volume increase regardless frequency , duration regularity . Some study report 30 % woman suffer heavy period lifetime . The first line treatment heavy bleeding medical . However , significant proportion woman require surgery . Until 80 , hysterectomy one surgical option often perform first line treatment . Since twenty year endometrial ablation become preferred option dysfunctional uterine bleeding avoids hysterectomy significant proportion patient suffer type problem . Endometrial ablation much less invasive morbid hysterectomy , however , many patient achieve complete amenorrhea endometrial ablation 15 % may require new intervention , hysterectomy , follow persistence menstrual problem . A Cochrane review publish 2013 showed satisfaction rate follow endometrial ablation high 70-80 % 35 % woman amenorrhea . The complete destruction endometrium important predictor success procedure . Studies show well result obtain surgery perform endometrium thin immediately follow menses follow administration hormonal agent cause atrophy endometrium . One agent study prepare endometrium ablation medroxyprogesterone acetate ( MPA ) injectables ( DMPA ) oral . Progestins antiproliferative effect endometrium . In recent year , numerous study examine use various agent preoperatively , include MPA DMPA facilitate surgery reduce thickness endometrium . However , study focus condition post-operative period promote therapeutic response intervention . The investigator hypothesis whether MPA administer immediate post-operative would inhibit proliferation endometrial cell responsible persistence menstruation optimize clinical response endometrial ablation .</brief_summary>
	<brief_title>The Effect Post Ablation Medroxyprogesterone Acetate Endometrial Amenorrhea Rates</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>endometrial ablation plan eavy menstrual bleeding No abnormality hysteroscopy No evidence hyperplasia neoplasia endometrial biopsy Hysterometry â‰¤ 10 cm preoperatively Any indication MPA Intrauterine pathology cause heavy bleed hormonal treatment provide postoperative period ( first 4 month ) preoperative hormonal therapy residual postoperative effect breastfeed future pregnancy plan menopausal woman endometrial ablation antecedent Suspected pelvic infection know Hematologic Disease Taking anticoagulant Taking progestin 6 month surgery</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>endometrial ablation</keyword>
</DOC>